NASDAQ:GWPH   GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00
A friend on Tradingview gave me a tip the other day when he said "GWPH is cheap right now. Temporary health industry dip. Great long term stock. " Well I finally got off my lqzy a$$ and looked it up today to find an evaluation that read as follows:
"GW Pharmaceuticals Plc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.81% during the next 3 months and, with 90% probability hold a price between $181.57 and $221.58 at the end of this period....Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate." (Stockinvest.us)
So I looked at the chart and said hmmmm, "that's a little pricey for me" and looked for a reason to say no (this is where options come in handy); I can't find one can you? Did I get in - the second 90% probability rating I found in the same day - you know I did :) Thanks for the tip Barkworth!
Good luck with your trades!

BTW that bullish candlestick pattern is Three White Soilders
After a rough week it's at least up considerably from where we started in spite of the US China trade war...looks good to me :)
Reply
light em up boys :)....I think this one's a real winner
Reply
This again appears again to be a good entry point looking back. Three white soldiers and rejection occurred around 173.00 a few days ago. Yesterday closed with a bullish engulfing candle and today we find ourselves bumping up against the same area. If we close above it, it will be a very good sign since after that the 1st point of resistance would be 176.48 and then 179.80.
Reply
ouch....rough entry
Reply
You got in. Well done! Good vibes, this is how a community is intended to work :-)

When pointed it out to you, it was trading at $1.55. It had just closed a gap down from a spike a few weeks back, and seemed like a potential to look for an entry. I had the same feeling as you: a little pricey by market cap. But the EU hasn't even approved Epidiolex yet. Once that will happen, we may be looking at another big leg up. That drug is a real winner.

Reply
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out